NewswireToday - /newswire/ -
San Jose, CA, United States, 2007/01/22 - In the October 17, 2006 issue of Biochemistry, researchers performed a study that characterized the oligomerization and seeding capacity of pGlu-amyloid peptides.
Their results identified pGlu-modified beta-amyloid peptides as displaying “up to 250-fold accelerated initial formation of aggregates compared to unmodified Abeta”1, adding further support to the idea that pGlu-amyloid peptides possess “biophysical characteristics that might be in particular crucial for the initiation of [Alzheimer’s disease] (1).” AnaSpec was one of the primary sources for the peptides used in this study.
For more information, visit our website.
AnaSpec, Inc., located in San Jose, CA, is a leading provider of integrated proteomics solutions to pharmaceutical, biotech, and academic research institutions throughout the world. With a vision for innovation through synergy, AnaSpec focuses on three core technologies: peptides, detection reagents, and combinatorial chemistry.AnaSpec carries a broad product line of biochemicals and reagents for basic research, high-throughput screening and drug discovery. In conjunction, AnaSpec provides premier custom services including peptide synthesis, antibody production, and assay development. AnaSpec holds a California Drug Manufacturing License (License #41747) and a FDA Registration for GMP Drug Manufacturing (Registration #2951078).
As a company founded by researchers, we recognize the inextricable connection between the quality of one's tools and the success of one's research. Since our inception, AnaSpec has had a longstanding reputation for the unsurpassed quality of our products. AnaSpec's full commitment to quality is exemplified by our ISO 9001:2000 certification. All products are manufactured according to strict ISO and GMP/GLP guidelines and are accompanied with certificates of analysis. AnaSpec's peptides are produced in our own manufacturing facilities located in San Jose, CA.
The scientific team at AnaSpec is staffed by experts in the fields of peptide technology, fluorescence technology, antibodies, and combinatorial chemistry. Our expertise in these complementary fields translates into both premium quality products and cutting-edge innovation.
Largest selection of peptides for Alzheimer research (200+ Amyloid Peptides) and phosphorylation studies (400+ Kinase and Phosphatase Substrates/Inhibitors)
Large number of phosphospecific antibodies, including phosphoserine antibodies exhibiting unrivalled selectivities
Leading fluorescence technologies generating new versatile fluorescent reagents such as HiLyte Fluor™ dyes and QXL™ quenchers useful for FRET and other fluorometric applications
Novel assay kits such as EnzoLyte™ AnaRed™ and EnzoLyte™ Rh110 Caspase 3 Assay Kits developed with greater selectivity and sensitivity for detection applications
Thousands of new building blocks and amino acid derivatives produced for medicinal and combinatorial chemistry
Complementing our full commitment to product quality, AnaSpec provides unparalleled customer support. Our professional customer support staff is always ready to answer your order and technical inquiries with personalized, attentive care. Online ordering and custom project reports are available at our website for efficient purchasing and planning. Whatever your need is, you can always depend on us to assist you in a prompt and professional manner.
Integrated Proteomics Solutions
More than simply providing products or services, AnaSpec is singularly focused on providing solutions for the most demanding research challenges. The synergy of AnaSpec's technologies combined with a premium placed on the values of quality, innovation, and service, make AnaSpec uniquely qualified as the leading provider of Integrated Proteomics Solutions™.
1. Schilling, S. et al Biochemistry 45, 12393 (2006)